CLINICAL-PATOGENETIC RATIONALE FOR THE USE OF GLYCOSAMINOGLYCANS IN THE TREATMENT OF PATIENTS WITH GLOMERULONEPHRITIS. Scientific and practical journal [Internet]. 2023 Dec. 10 [cited 2026 Jun. 24];28(4):88-93. Available from: https://art-of-medicine.ifnmu.edu.ua/index.php/aom/article/view/1060